Aspirin can reduce the risk of colon cancer and the recurrence of colorectal adenoma, but only at doses high enough to incur risk of GI complications, a new study shows (Gastroenterology.

An analysis of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial has shown that patients with ST-segment-elevation MI (STEMI) undergoing ...

Results presented at the Musculoskeletal Infection Society Annual Meeting showed use of aspirin was associated with decreased ...

Aspire’s sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes ...

Please provide your email address to receive an email when new articles are posted on . The proportion of patients receiving low-dose aspirin increased from 7.65% in 2012 to 55.29% in 2022. A low-dose ...

HUMACAO, PUERTO RICO AND NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected ...

Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete Test results support the next development step with Phase 1clinical trial expected ...